Cargando…

A nanomicelle with miR-34a and doxorubicin reverses the drug resistance of cisplatin in esophageal carcinoma cells by inhibiting SIRT1 signal pathway

BACKGROUND: Esophageal carcinoma (EC) is one of the most deadly malignant tumors in the world. Surgery, combined with chemotherapy or radiotherapy, is the traditional strategy for the treatment of EC. Cisplatin (CDDP) is a common chemotherapy drug widely used to treat EC due to its powerful anti-tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Jun, Wang, Yuezhen, Wang, Zhun, Xie, Tieming, Yan, Fengqin, Wang, Lei, Hua, Jianfeng, Wang, Fangzheng, Fu, Zhenfu, Ye, Zhimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798537/ https://www.ncbi.nlm.nih.gov/pubmed/35117782 http://dx.doi.org/10.21037/tcr-19-975

Ejemplares similares

Inter- and intra-observer reproducibility of ADC measurements in esophageal carcinoma primary tumors
por: Ye, Zhimin, et al.
Publicado: (2017)

Bioinformatics-based analysis of the lncRNA–miRNA–mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma
por: Ye, Zhimin, et al.
Publicado: (2020)

ADC correlation with Sirtuin1 to assess early chemoradiotherapy response of locally advanced esophageal carcinoma patients
por: Chen, Ying, et al.
Publicado: (2019)

Gemcitabine/cisplatin induction chemotherapy before concurrent chemotherapy and intensity-modulated radiotherapy improves outcomes for locoregionally advanced nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Therapeutic patterns and outcomes in older patients (aged ≥65 years) with stage II-IVB Nasopharyngeal Carcinoma: an investigational study from SEER database
por: Piao, Yongfeng, et al.
Publicado: (2020)

Clinical and imaging characteristics of 53 ulcers of post-radiation nasopharyngeal necrosis in patients with nasopharyngeal carcinoma
por: Yan, Fengqin, et al.
Publicado: (2016)

Reversal of multidrug resistance in leukemia cells using a transferrin-modified nanomicelle encapsulating both doxorubicin and psoralen
por: Wang, He-Wen, et al.
Publicado: (2020)

Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis
por: Fangzheng, Wang, et al.
Publicado: (2017)

Addition of 5-fluorouracil to first-line induction chemotherapy with docetaxel and cisplatin before concurrent chemoradiotherapy does not improve survival in locoregionally advanced nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Combined radiotherapy and chemotherapy versus radiotherapy alone in elderly patients with nasopharyngeal carcinoma: A SEER population-based study
por: Lu, Yan, et al.
Publicado: (2021)

Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy
por: Zhang, Xinyi, et al.
Publicado: (2020)

Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance
por: Guo, Weihong, et al.
Publicado: (2018)

Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma
por: Wang, Fangzheng, et al.
Publicado: (2020)

Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity-modulated radiotherapy: A retrospective matched analysis
por: Wang, Fangzheng, et al.
Publicado: (2020)

The Usefulness of Pretreatment MR-Based Radiomics on Early Response of Neoadjuvant Chemotherapy in Patients With Locally Advanced Nasopharyngeal Carcinoma
por: Yongfeng, Piao, et al.
Publicado: (2021)

Nanomicelles loaded with doxorubicin and curcumin for alleviating multidrug resistance in lung cancer
por: Gu, Yue, et al.
Publicado: (2016)

Biodegradable Redox-Sensitive Star Polymer Nanomicelles for Enhancing Doxorubicin Delivery
por: Li, Meng, et al.
Publicado: (2019)

Complex polymeric nanomicelles co-delivering doxorubicin and dimethoxycurcumin for cancer chemotherapy
por: Sohail, Muhammad, et al.
Publicado: (2022)

One-pot synthesis and enzyme-responsiveness of amphiphilic doxorubicin prodrug nanomicelles for cancer therapeutics
por: Han, Ling-Na, et al.
Publicado: (2022)

Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience
por: Wang, Fangzheng, et al.
Publicado: (2017)

Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma
por: Ye, Zhimin, et al.
Publicado: (2019)

Different Risk Target Volumes for Nasopharyngeal Carcinoma Treated with Simultaneous Integrated Boost Intensity-Modulated Radiotherapy
por: Wang, Fangzheng, et al.
Publicado: (2020)

Optimization of the margin expanded from the clinical to the planned target volume during intensity-modulated radiotherapy for nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma
por: Fangzheng, Wang, et al.
Publicado: (2017)

Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis
por: Wang, Fangzheng, et al.
Publicado: (2018)

Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity
por: Zhu, Jie-Ning, et al.
Publicado: (2017)

Tumor Microenvironment Responsive Nanomicelle with Folic Acid Modification Co-Delivery of Doxorubicin/Shikonin for Triple Negative Breast Cancer Treatment
por: Zhong, Wu, et al.
Publicado: (2023)

A Retrospective Comparison of Taxane and Fluorouracil-based Chemoradiotherapy in Patients with Inoperable Esophageal Squamous Cell Carcinoma
por: Sun, Xiaojiang, et al.
Publicado: (2016)

MiR-34a Regulates Nasopharyngeal Carcinoma Radiosensitivity by Targeting SIRT1
por: Liu, Yang, et al.
Publicado: (2020)

Predictive value of plasma D-dimer levels in patients with advanced non-small-cell lung cancer
por: Wang, Yuezhen, et al.
Publicado: (2015)

Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness
por: Ma, Wei, et al.
Publicado: (2015)

MiR-140 Resensitizes Cisplatin-Resistant NSCLC Cells to Cisplatin Treatment Through the SIRT1/ROS/JNK Pathway
por: Lin, Zhilai, et al.
Publicado: (2020)

miR-195 is a key regulator of Raf1 in thyroid cancer
por: Wang, Fangzheng, et al.
Publicado: (2015)

miR-34a/SIRT6 in squamous differentiation and cancer
por: Dotto, G Paolo, et al.
Publicado: (2014)

Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling
por: Cui, Wei, et al.
Publicado: (2020)

Co-delivery of doxorubicin and shRNA of Beclin1 by folate receptor targeted pullulan-based multifunctional nanomicelles for combinational cancer therapy
por: Chen, Lili, et al.
Publicado: (2018)

Exosome-mediated miR-25/miR-203 as a potential biomarker for esophageal squamous cell carcinoma: improving early diagnosis and revealing malignancy
por: Liu, Zhun, et al.
Publicado: (2021)

Curcumin-Encapsulated Nanomicelles Improve Cellular Uptake and Cytotoxicity in Cisplatin-Resistant Human Oral Cancer Cells
por: Kumbar, Vijay M., et al.
Publicado: (2022)

Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma
por: Cui, Xiaobin, et al.
Publicado: (2014)

MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
por: Zheng, Shun-Zhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_po2qcrrb0i7cedlosvq6ll0ika